A popular blood pressure medication has been recalled due to concerns of potential contamination with another drug.
Glenmark Pharmaceuticals Inc in the US has recalled more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets, sold under the brand name Ziac. The recall notice issued by the Food and Drug Administration indicated that the tablets may have been contaminated with other substances.
These tablets are commonly prescribed for managing high blood pressure, or hypertension, by blocking beta-1 receptors in the heart to regulate its rhythm, as reported by WebMD.
The recall notice revealed that testing of samples detected the presence of ezetimibe, a drug used to address high cholesterol levels. The FDA classified the recall, issued on December 1, as Class III, indicating that exposure to the affected product is unlikely to cause severe health issues.
The impacted pills are available in 2.5mg and 6.25mg strengths. The recall affects specific packages, including 30-count bottles with NDC-68462-878-30, 100-count bottles with NDC-68462-878-01, and 500-count bottles with NDC-68462-878-05.
The affected lot numbers have expiration dates ranging from November 2025 to May 2026, with a total of 11,136 bottles being part of the recall. At present, the FDA has not provided guidance on what actions patients should take if their medication is impacted by the recall.